Based on the Balchem Corporation stock forecast from 1 analysts, the average analyst target price for Balchem Corporation is USD 185.00 over the next 12 months. Balchem Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Balchem Corporation is Slightly Bearish, which is based on 4 positive signals and 9 negative signals. At the last closing, Balchem Corporation’s stock price was USD 182.44. Balchem Corporation’s stock price has changed by +2.63% over the past week, +8.85% over the past month and +50.03% over the last year.
No recent analyst target price found for Balchem Corporation
No recent average analyst rating found for Balchem Corporation
Company Overview Balchem Corporation
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey. Address: 5 Paragon Drive, Montvale, NJ, United States, 07645 Read Less
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Hu...Read More
Frequently Asked Questions About Balchem Corporation (BCPC) Stock
Based on ratings from 1 analysts Balchem Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
BCPC stock's dividend yield is 0.44%.
Our analysis grades BCPC stock's dividend yield at F. This means that BCPC stock's dividend yield is above 17% of the stocks in the Specialty Chemicals sector in the NSD exchange.
Based on this BCPC may be a poor dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for BCPC is USD 185.00 over the next 12 months. The maximum analyst target price is USD 185 while the minimum anlayst target price is USD 185.
BCPC stock's Price/Earning ratio is 48.34.
Our analysis grades BCPC stock's Price / Earning ratio at F. This means that BCPC stock's Price/Earning ratio is above 85% of the stocks in the Specialty Chemicals sector in the NSD exchange.
Based on this BCPC may be a overvalued for its sector.
The last closing price of BCPC's stock was USD 182.44.
The most recent market capitalization for BCPC is USD 5.86B.
Based on targets from 1 analysts, the average taret price for BCPC is projected at USD 185.00 over the next 12 months.
This means that BCPC's stock price may go up by +1.40% over the next 12 months.
We can't find any ETFs which contains Balchem Corporation's stock.
As per our most recent records Balchem Corporation has 1,300 Employees.
Balchem Corporation's registered address is 5 Paragon Drive, Montvale, NJ, United States, 07645.
You can get more information about it from Balchem Corporation's website at https://www.balchem.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Balchem Corporation (BCPC) Stock
Based on ratings from 1 analysts Balchem Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
BCPC stock's dividend yield is 0.44%.
Our analysis grades BCPC stock's dividend yield at F. This means that BCPC stock's dividend yield is above 17% of the stocks in the Specialty Chemicals sector in the NSD exchange.
Based on this BCPC may be a poor dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for BCPC is USD 185.00 over the next 12 months. The maximum analyst target price is USD 185 while the minimum anlayst target price is USD 185.
BCPC stock's Price/Earning ratio is 48.34.
Our analysis grades BCPC stock's Price / Earning ratio at F. This means that BCPC stock's Price/Earning ratio is above 85% of the stocks in the Specialty Chemicals sector in the NSD exchange.
Based on this BCPC may be a overvalued for its sector.
The last closing price of BCPC's stock was USD 182.44.
The most recent market capitalization for BCPC is USD 5.86B.
Based on targets from 1 analysts, the average taret price for BCPC is projected at USD 185.00 over the next 12 months.
This means that BCPC's stock price may go up by +1.40% over the next 12 months.
We can't find any ETFs which contains Balchem Corporation's stock.
As per our most recent records Balchem Corporation has 1,300 Employees.
Balchem Corporation's registered address is 5 Paragon Drive, Montvale, NJ, United States, 07645.
You can get more information about it from Balchem Corporation's website at https://www.balchem.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BCPC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
